Lung cancer screening with low-dose scans and metabolite testing in smokers
Checks how a lung cancer screening program works for smokers aged 45 to 74.
Plain-language title generated from the registry record
Registry title: Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Key facts
- Where
- Botucatu, BrazilSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for current smokers or recent former smokers aged 45 to 74 who have never had lung cancer screening.
- Age
- 45 to 74 years
- Sex
- All sexes can join.
- Earlier treatment
- The trial is looking for people who have never taken part in a lung cancer screening program.
Main reasons for not taking part
- Advanced chronic heart, lung, liver, kidney or metabolic disease that limits life expectancy or rules out surgery meant to remove all of the disease
- Being treated for tuberculosis or other granulomatous diseases
- Earlier cancer that could spread to the lungs
- Pregnancy
- Unable to have a low-dose chest CT scan, or earlier radiotherapy to the chest
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 74 years old?
Source: NCT06376097, who can take part
Where in Brazil
- Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB)Botucatu, BrazilContact: Erica HasimotoTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- AstraZeneca
- Trial code
- NCT06376097
- Record updated
- 1 September 2026
- Original description
Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.Read full original descriptionShow less
Implementation of a Lung Cancer Screening Program in a Public Service, Using Low-dose Tomography and Metabolomics Evaluation
Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.
Inclusion: Age between 45 and 74 years old; Smoker with a smoking history of at least 30 pack-years or former smoker who has quit smoking for less than 15 years; Never having participated in a lung cancer screening program ; Signing of the free and informed consent form.
Exclusion: Patients with chronic diseases (cardiovascular, pulmonary, hepatic, renal or metabolic) at an advanced stage that limit life expectancy or make it impossible to perform a curative surgical procedure; Patients being treated for tuberculosis or other granulomatous diseases; Patients diagnosed with previous neoplasm(s) that could develop lung metastases; Pregnant women; Patients who, for some reason, are unable to undergo low-dose chest computed tomography; Patients previously submitted to thoracic radiotherapy.